Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs. Company website: www.scinai.com


Pharmaceutical

Scinai Immunotherapeutics

Amir Reichman

Dalit Fischer

Maxim Leykin

Gal Ron

Merav Kamensky

Elad Mark 

Joshua E. Phillipson

Uri Ben-Or

Tamar Ben-Yedidia

Dalit Weinstein Fischer

The leadership team at BiondVax Pharmaceuticals has a history of experience in marketing, business development, and coordinating Canada-Israel partnerships. They also have a strong educational background in immunology from the University of Toronto, Weizmann Institute of Science, and Tel Aviv University.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Scinai Immunotherapeutics

Board of Directors

CEO and Executive Team